Envoy Medical Ratios (2020-2026) | COCH

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
-85.96%-2,590.00%-124.36%-157.14%-398.75%-440.00%-159.32%-630.88%-603.57%1,228.57%-391.30%-200.00%-864.29%-642.67%-702.56%
EBT Margin (Quarter)
10,919.84%-5,746.49%1,999.01%-1,614.29%-4,231.25%-7,076.84%-8,338.98%-7,329.41%-9,350.00%-11,745.24%-12,178.26%-7,300.00%-14,711.90%-8,513.33%-15,279.49%
EBIT Margin (Quarter)
-3,150.88%-14,530.00%-4,834.62%-7,111.11%-4,231.25%-7,076.84%-8,277.97%-7,135.29%-8,878.57%-10,830.95%-11,102.17%-6,500.00%-13,590.48%-8,513.33%-15,279.49%
EBITDA Margin (Quarter)
-2,354.39%-57,405.00%-16,991.03%-21,026.98%1,952.50%-5,154.74%-10,628.81%-5,805.88%-10,644.64%-11,000.00%-10,852.17%-7,297.44%-15,435.71%-8,781.33%-11,158.97%
Operating Margin (Quarter)
-3,150.88%-14,530.00%-4,834.62%-7,111.11%-4,231.25%-7,076.84%-8,277.97%-7,135.29%-8,878.57%-10,830.95%-11,102.17%-6,500.00%-13,590.48%-8,513.33%-15,279.49%
Net Margin (Quarter)
-2,349.12%-57,385.00%-16,991.03%-21,025.40%1,750.00%-6,572.63%-12,940.68%-7,811.76%-13,107.14%-18,300.00%-13,556.52%-8,900.00%-18,445.24%-10,316.00%-14,617.95%
FCF Margin (Quarter)
-9,215.97%-12,100.00%-3,935.90%-6,420.63%1,296.25%-11,753.68%-9,657.63%-7,197.06%-6,750.00%-10,850.00%-8,110.87%-5,719.23%-10,311.90%-7,809.33%-15,541.03%
Efficiency
Inventory Average (Quarter)
1.40M1.43M1.52M1.61M1.67M1.68M1.62M1.61M1.59M1.52M
Assets Average (Quarter)
425.57M427.39M426.93M426.62M426.75M427.49M215.18M24.24M45.48M33.13M14.74M8.38M7.61M8.07M10.47M10.96M10.14M9.04M8.37M19.19M
Equity Average (Quarter)
-38.29M-35.55M-38.86M-35.27M-25.88M-25.86M-30.87M-41.84M-46.31M-20.17M1.50M-4.60M-9.91M-15.47M-18.69M-21.53M-27.04M-18.76M-9.91M-1.00M
Invested Capital (Quarter)
-38.15M-32.76M-44.96M-25.59M-26.18M-25.55M-35.86M-47.49M-45.12M5.01M-1.47M-7.43M-12.40M-18.54M-18.84M-24.22M-29.86M-7.66M-12.16M10.16M
Asset Utilization Ratio (Quarter)
0.000.010.020.040.040.030.020.020.020.020.030.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-135.67-36.76-18.83-11.85-10.32-8.13-12.12
Debt to Equity (Quarter)
0.00-0.010.05-0.18-0.20-0.77-0.50-0.95-0.94
Debt Ratio (Quarter)
0.000.130.010.040.371.530.812.222.82
Equity Ratio (Quarter)
-0.09-0.08-0.11-0.06-0.06-0.06-14.16-1.03-1.000.23-0.21-0.88-1.84-1.97-1.63-2.33-3.02-0.94-1.420.34
Times Interest Earned (Quarter)
-135.67-36.76-18.83-11.85-10.32-8.13-12.12
Dividends & Payouts
FCF Payout Ratio (Quarter)
-0.13-0.33-0.14-0.440.63-0.62
Valuation
Enterprise Value (Quarter)
-1.74M-1.03M-0.13M-0.30M-0.18M-1.11M-0.07M-22.24M-4.22M-4.95M-1.75M-4.42M-5.48M-5.31M-5.29M-3.56M-3.74M-25.25M
Return Ratios
Return on Sales (Quarter)
1.00%-0.84%0.09%-0.18%-0.42%-0.71%-0.83%-0.73%-0.94%-1.17%-1.22%-0.73%-1.47%-0.85%-1.53%
Return on Capital Employed (Quarter)
-1.41%-1.54%-1.50%-1.22%-3.34%-63.60%-35.85%-71.15%-246.17%-1,411.53%4,414.68%2,128.20%-657.35%-578.64%-919.39%-38,921.90%697.57%-331.31%
Return on Invested Capital (Quarter)
0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.02%-0.03%-0.03%-0.02%-0.02%-0.02%-0.02%-0.03%-0.01%
Return on Equity (Quarter)
0.00%0.00%0.00%-0.01%-0.01%-0.01%0.00%0.00%0.00%-0.07%0.04%0.02%0.01%0.01%0.01%0.01%0.01%0.02%0.24%